The Prevalence of Multiple Sclerosis in 3 US Communities

Introduction We estimated the prevalence of multiple sclerosis (MS) in 3 large geographic areas in the southern, middle, and northern United States. Methods The primary data source was medical records from office visits to private neurologists' practices or to neurology departments in tertiary care facilities during a 3-year period. Additional data sources included patient advocacy groups, nursing homes, and general practitioners. Results Three-year US age-adjusted prevalence estimates for the study areas varied substantially. The prevalence was lowest (47.2 per 100,000 population) in the Texas study area (33°30′ north latitude), intermediate (86.3 per 100,000 population) in the Missouri study area (39°07′ north latitude), and highest (109.5 per 100,000 population) in the Ohio study area (41°24′ north latitude). The geographic differences remained strong after age-adjustment to the world standard population. The inverse association between UV light exposure and MS prevalence estimates was consistent with this observed latitude gradient. In all 3 areas, MS prevalence was highest among women, people aged 40 to 59 years, and non-Hispanics. Conclusion These results provide necessary prevalence estimates for community cluster investigations and establish baseline estimates for future studies to evaluate temporal trends in disease prevalence.

[1]  Harold W. Jaffe,et al.  Centers for Disease Control , 2016, International Encyclopedia of Public Health.

[2]  J. Malone,et al.  Multiple sclerosis prevalence and possible lead exposure , 2008, Journal of the Neurological Sciences.

[3]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[4]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[5]  M. Hutchinson,et al.  Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland , 2005, Journal of Neurology.

[6]  D. Williamson,et al.  Challenges in Addressing Community Concerns Regarding Clusters of Multiple Sclerosis and Potential Environmental Exposures , 2004, Neuroepidemiology.

[7]  M. Wallin,et al.  Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography , 2004, Annals of neurology.

[8]  R. McClelland,et al.  Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000 , 2003, Neurology.

[9]  R. Zivadinov,et al.  The Use of Standardized Incidence and Prevalence Rates in Epidemiological Studies on Multiple Sclerosis , 2003, Neuroepidemiology.

[10]  M. Filippi,et al.  Primary Progressive Multiple Sclerosis , 2002, Topics in Neuroscience.

[11]  S. Reingold,et al.  Prevalence estimates for MS in the United States and evidence of an increasing trend for women , 2002, Neurology.

[12]  Terence Dwyer,et al.  Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.

[13]  G. Rosati The prevalence of multiple sclerosis in the world: an update , 2001, Neurological Sciences.

[14]  Mustafa Dosemeci,et al.  Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates , 2000, Occupational and environmental medicine.

[15]  M. Hernán,et al.  Geographic variation of MS incidence in two prospective studies of US women , 1999, Neurology.

[16]  B. Weinshenker,et al.  Epidemiology of multiple sclerosis. , 1996, Neurologic clinics.

[17]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[18]  S. Reingold,et al.  Revised estimate of the prevalence of multiple sclerosis in the united states , 1992, Annals of neurology.

[19]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[20]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[21]  H. M. Baum,et al.  The incidence and prevalence of reported multiple sclerosis , 1981, Annals of neurology.

[22]  E. Operskalski,et al.  Multiple sclerosis among Spanish‐surnamed Californians , 1978, Neurology.

[23]  C. Schoenborn,et al.  Age adjustment using the 2000 projected U.S. population. , 2001, Healthy People 2010 statistical notes : from the Centers for Disease Control and Prevention/National Center for Health Statistics.

[24]  G. Dean How many people in the world have multiple sclerosis? , 1994, Neuroepidemiology.

[25]  A. Sadovnick,et al.  The geographic distribution of multiple sclerosis: a review. , 1993, Neuroepidemiology.

[26]  R. Hamman,et al.  Higher than expected prevalence of multiple sclerosis in northern Colorado: dependence on methodologic issues. , 1986, Neuroepidemiology.